USD 2.06
(-3.74%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 3.48 Million USD | -45.65% |
2022 | 6.4 Million USD | 4.89% |
2021 | 6.1 Million USD | -10.59% |
2020 | 6.82 Million USD | 185.95% |
2019 | 2.38 Million USD | 13.53% |
2018 | 2.1 Million USD | 26.84% |
2017 | 1.65 Million USD | 22.53% |
2016 | 1.35 Million USD | 30.13% |
2015 | 1.04 Million USD | -15.19% |
2014 | 1.22 Million USD | 49.82% |
2013 | 818.72 Thousand USD | -28.81% |
2012 | 1.15 Million USD | -1.48% |
2011 | 1.16 Million USD | 74.72% |
2010 | 668.2 Thousand USD | 5.3% |
2009 | 634.58 Thousand USD | 2.05% |
2008 | 621.84 Thousand USD | 12.85% |
2007 | 551.03 Thousand USD | 12.52% |
2006 | 489.73 Thousand USD | 40.98% |
2005 | 347.39 Thousand USD | -6.51% |
2004 | 371.56 Thousand USD | -1.96% |
2003 | 378.98 Thousand USD | -0.69% |
2002 | 381.62 Thousand USD | -36.46% |
2001 | 600.63 Thousand USD | 2.35% |
2000 | 586.86 Thousand USD | 5.57% |
1999 | 555.88 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 2.58 Million USD | -17.75% |
2024 Q1 | 3.14 Million USD | -9.59% |
2023 Q1 | 6.63 Million USD | 3.65% |
2023 Q3 | 4.67 Million USD | -11.39% |
2023 Q2 | 5.27 Million USD | -20.49% |
2023 FY | 3.48 Million USD | -45.65% |
2023 Q4 | 3.48 Million USD | -25.56% |
2022 Q3 | 6.88 Million USD | 1.66% |
2022 FY | 6.4 Million USD | 4.89% |
2022 Q4 | 6.4 Million USD | -6.96% |
2022 Q1 | 6.01 Million USD | -1.45% |
2022 Q2 | 6.77 Million USD | 12.53% |
2021 Q1 | 8.05 Million USD | 18.0% |
2021 Q2 | 7.56 Million USD | -6.16% |
2021 Q4 | 6.1 Million USD | -12.37% |
2021 Q3 | 6.96 Million USD | -7.87% |
2021 FY | 6.1 Million USD | -10.59% |
2020 Q3 | 5.63 Million USD | 53.61% |
2020 Q2 | 3.66 Million USD | 18.72% |
2020 Q4 | 6.82 Million USD | 21.24% |
2020 FY | 6.82 Million USD | 185.95% |
2020 Q1 | 3.08 Million USD | 29.33% |
2019 Q1 | 2.5 Million USD | 19.24% |
2019 Q3 | 2.73 Million USD | 6.5% |
2019 Q4 | 2.38 Million USD | -12.79% |
2019 FY | 2.38 Million USD | 13.53% |
2019 Q2 | 2.57 Million USD | 2.51% |
2018 Q1 | 1.8 Million USD | 8.55% |
2018 FY | 2.1 Million USD | 26.84% |
2018 Q2 | 1.71 Million USD | -4.57% |
2018 Q4 | 2.1 Million USD | 7.92% |
2018 Q3 | 1.94 Million USD | 13.45% |
2017 Q2 | 1.26 Million USD | -6.39% |
2017 Q1 | 1.35 Million USD | 4.18% |
2017 FY | 1.65 Million USD | 22.53% |
2017 Q4 | 1.65 Million USD | 4.55% |
2017 Q3 | 1.58 Million USD | 25.2% |
2016 Q2 | 1.12 Million USD | 8.01% |
2016 FY | 1.35 Million USD | 30.13% |
2016 Q3 | 1.07 Million USD | -4.43% |
2016 Q1 | 1.04 Million USD | -17.36% |
2016 Q4 | 1.29 Million USD | 21.01% |
2015 Q2 | 1.41 Million USD | 15.16% |
2015 Q1 | 1.22 Million USD | -21.92% |
2015 Q4 | 1.25 Million USD | -2.85% |
2015 Q3 | 1.29 Million USD | -8.28% |
2015 FY | 1.04 Million USD | -15.19% |
2014 Q3 | 1.44 Million USD | 40.6% |
2014 Q4 | 1.57 Million USD | 9.06% |
2014 Q2 | 1.02 Million USD | 25.14% |
2014 FY | 1.22 Million USD | 49.82% |
2014 Q1 | 818.72 Thousand USD | -14.36% |
2013 FY | 818.72 Thousand USD | -28.81% |
2013 Q4 | 956 Thousand USD | -13.63% |
2013 Q3 | 1.1 Million USD | -12.35% |
2013 Q2 | 1.26 Million USD | 9.8% |
2013 Q1 | 1.15 Million USD | -1.72% |
2012 Q1 | 1.16 Million USD | 9.94% |
2012 Q3 | 1.25 Million USD | -5.01% |
2012 FY | 1.15 Million USD | -1.48% |
2012 Q2 | 1.31 Million USD | 12.85% |
2012 Q4 | 1.17 Million USD | -6.49% |
2011 Q4 | 1.06 Million USD | -2.57% |
2011 FY | 1.16 Million USD | 74.72% |
2011 Q2 | 830.15 Thousand USD | 24.24% |
2011 Q1 | 668.2 Thousand USD | -3.07% |
2011 Q3 | 1.08 Million USD | 31.29% |
2010 Q1 | 634.58 Thousand USD | -14.0% |
2010 FY | 668.2 Thousand USD | 5.3% |
2010 Q4 | 689.33 Thousand USD | 8.92% |
2010 Q3 | 632.89 Thousand USD | 0.91% |
2010 Q2 | 627.21 Thousand USD | -1.16% |
2009 Q3 | 707.88 Thousand USD | 10.44% |
2009 Q4 | 737.92 Thousand USD | 4.24% |
2009 FY | 634.58 Thousand USD | 2.05% |
2009 Q1 | 621.84 Thousand USD | 10.59% |
2009 Q2 | 640.95 Thousand USD | 3.07% |
2008 Q3 | 563.77 Thousand USD | -1.9% |
2008 FY | 621.84 Thousand USD | 12.85% |
2008 Q4 | 562.3 Thousand USD | -0.26% |
2008 Q2 | 574.7 Thousand USD | 4.3% |
2008 Q1 | 551.03 Thousand USD | 11.2% |
2007 FY | 551.03 Thousand USD | 12.52% |
2007 Q4 | 495.51 Thousand USD | -3.42% |
2007 Q3 | 513.05 Thousand USD | 11.07% |
2007 Q2 | 461.91 Thousand USD | -5.68% |
2007 Q1 | 489.73 Thousand USD | 21.73% |
2006 Q4 | 402.32 Thousand USD | -4.97% |
2006 Q1 | 347.39 Thousand USD | 2.94% |
2006 FY | 489.73 Thousand USD | 40.98% |
2006 Q2 | 371.98 Thousand USD | 7.08% |
2006 Q3 | 423.36 Thousand USD | 13.81% |
2005 Q3 | 358.45 Thousand USD | 0.33% |
2005 Q2 | 357.28 Thousand USD | -3.85% |
2005 Q1 | 371.56 Thousand USD | -2.92% |
2005 Q4 | 337.46 Thousand USD | -5.86% |
2005 FY | 347.39 Thousand USD | -6.51% |
2004 Q2 | 350.23 Thousand USD | -7.59% |
2004 Q1 | 378.98 Thousand USD | 2.59% |
2004 FY | 371.56 Thousand USD | -1.96% |
2004 Q4 | 382.73 Thousand USD | 0.47% |
2004 Q3 | 380.93 Thousand USD | 8.76% |
2003 Q2 | 360.84 Thousand USD | -5.45% |
2003 Q1 | 381.62 Thousand USD | -28.03% |
2003 Q4 | 369.42 Thousand USD | -5.17% |
2003 Q3 | 389.58 Thousand USD | 7.97% |
2003 FY | 378.98 Thousand USD | -0.69% |
2002 Q1 | 600.63 Thousand USD | -7.6% |
2002 Q2 | 561.61 Thousand USD | -6.5% |
2002 Q3 | 543.61 Thousand USD | -3.2% |
2002 Q4 | 530.23 Thousand USD | -2.46% |
2002 FY | 381.62 Thousand USD | -36.46% |
2001 Q2 | 608.63 Thousand USD | 3.71% |
2001 Q3 | 643.51 Thousand USD | 5.73% |
2001 Q4 | 650.01 Thousand USD | 1.01% |
2001 Q1 | 586.86 Thousand USD | -8.5% |
2001 FY | 600.63 Thousand USD | 2.35% |
2000 Q4 | 641.39 Thousand USD | -0.76% |
2000 FY | 586.86 Thousand USD | 5.57% |
2000 Q2 | 626.31 Thousand USD | 0.0% |
2000 Q3 | 646.3 Thousand USD | 3.19% |
1999 FY | 555.88 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | 80.526% |
AngioDynamics, Inc. | 60.61 Million USD | 94.257% |
AtriCure, Inc. | 67.89 Million USD | 94.873% |
Avinger, Inc. | 5.29 Million USD | 34.29% |
Azenta, Inc. | 128.19 Million USD | 97.284% |
BioLife Solutions, Inc. | 43.45 Million USD | 91.989% |
The Cooper Companies, Inc. | 735.6 Million USD | 99.527% |
Daxor Corporation | - USD | -Infinity% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | 31.063% |
Femasys Inc. | 667.11 Thousand USD | -421.842% |
GlucoTrack, Inc. | - USD | -Infinity% |
Harvard Bioscience, Inc. | 24.71 Million USD | 85.915% |
Hologic, Inc. | 679.8 Million USD | 99.488% |
ICU Medical, Inc. | 709.36 Million USD | 99.509% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 99.715% |
LeMaitre Vascular, Inc. | 52.33 Million USD | 93.348% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -306.334% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -306.334% |
Masimo Corporation | 545 Million USD | 99.361% |
Microbot Medical Inc. | - USD | -Infinity% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -115.264% |
Merit Medical Systems, Inc. | 303.87 Million USD | 98.854% |
Nephros, Inc. | 2.47 Million USD | -40.943% |
NovoCure Limited | 38.15 Million USD | 90.875% |
NEXGEL, Inc. | 1.31 Million USD | -163.935% |
NEXGEL, Inc. | 1.31 Million USD | -163.935% |
Singular Genomics Systems, Inc. | 13.57 Million USD | 74.349% |
OraSure Technologies, Inc. | 47.61 Million USD | 92.688% |
Pro-Dex, Inc. | 15.26 Million USD | 77.2% |
Pulse Biosciences, Inc. | - USD | -Infinity% |
Predictive Oncology Inc. | 494.37 Thousand USD | -604.184% |
Precision Optics Corporation, Inc. | 2.86 Million USD | -21.38% |
QuidelOrtho Corporation | 577.8 Million USD | 99.397% |
Repligen Corporation | 202.32 Million USD | 98.279% |
Sanara MedTech Inc. | 4.71 Million USD | 26.205% |
STAAR Surgical Company | 35.13 Million USD | 90.09% |
Sharps Technology, Inc. | 1.7 Million USD | -103.688% |
Utah Medical Products, Inc. | 9.58 Million USD | 63.668% |
DENTSPLY SIRONA Inc. | 624 Million USD | 99.442% |
Jin Medical International Ltd. | 5.05 Million USD | 31.106% |